Investor Relations


Medicus Pharma Ltd. (TSXV:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets.

Through our diverse experience and extensive industry network, we are building Medicus into a leading pharmaceutical company, committed to delivering better treatment outcomes and alleviate pain and suffering.

Utilizing a thesis driven collaborative process, we identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization.

We look into opportunities across all therapeutics areas where an unmet need exists for improved patient safety and efficacy.

Medicus is opportunistically exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships.

View SEDAR Filings

Corporate Governance Policies
and Procedures